The clinical importance of the anti-inflammatory vagovagal reflex

Handbook of Clinical Neurology

Volumn 117, Issue , 2013, Pages 119-134

  Boeckxstaens, G ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Acetylcholine; Alpha7 nicotinic receptor; Autonomic nervous system; Immune system; Immune mediated diseases; Inflammation; Sepsis; Vagus nerve

Indexed keywords

ACETYLCHOLINE; BUNGAROTOXIN RECEPTOR;

ANIMAL; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM; HUMAN; IMMUNE SYSTEM; IMMUNE-MEDIATED DISEASES; IMMUNOMODULATION; INFLAMMATION; NERVE TRACT; PATHOLOGY; PHYSIOLOGY; REFLEX; SEPSIS; VAGUS NERVE; VAGUS NERVE STIMULATION;

ACETYLCHOLINE; ALPHA7 NICOTINIC RECEPTOR; AUTONOMIC NERVOUS SYSTEM; IMMUNE SYSTEM; IMMUNE-MEDIATED DISEASES; INFLAMMATION; SEPSIS; VAGUS NERVE;

ANIMALS; CENTRAL NERVOUS SYSTEM; HUMANS; IMMUNE SYSTEM; INFLAMMATION; NEURAL PATHWAYS; NEUROIMMUNOMODULATION; REFLEX; VAGUS NERVE STIMULATION;

EID: 84884919836     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-53491-0.00011-0     Document Type: Chapter

References (144)

1. Abraham C., Medzhitov R. Interactions between the host innate immune system and microbes in inflammatory bowel disease. Gastroenterology 2011, 140:1729-1737.
2. Bai A., Guo Y., Lu N. The effect of the cholinergic anti-inflammatory pathway on experimental colitis. Scand J Immunol 2007, 66:538-545.
3. Barone L., Colicchio G., Policicchio D., et al. Effect of vagal nerve stimulation on systemic inflammation and cardiac autonomic function in patients with refractory epilepsy. Neuroimmunomodulation 2007, 14:331-336.
4. Beekwilder J.P., Beems T. Overview of the clinical applications of vagus nerve stimulation. J Clin Neurophysiol 2010, 27:130-138.
5. Bellinger D.L., Millar B.A., Perez S., et al. Sympathetic modulation of immunity: relevance to disease. Cell Immunol 2008, 252:27-56.
6. Bencherif M., Lippiello P.M., Lucas R., et al. Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases. Cell Mol Life Sci 2011, 68:931-949.
7. Berg D.K., Conroy W.G. Nicotinic alpha 7 receptors: synaptic options and downstream signaling in neurons. J Neurobiol 2002, 53:512-523.
8. Bernik T.R., Friedman S.G., Ochani M., et al. Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med 2002, 195:781-788.
9. Bischoff S.C. Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat Rev Immunol 2007, 7:93-104.
10. Bischoff S.C. Food allergy and eosinophilic gastroenteritis and colitis. Curr Opin Allergy Clin Immunol 2010, 10:238-245.
11. Bitto A., Polito F., Altavilla D., et al. Melanocortins protect against multiple organ dysfunction syndrome in mice. Br J Pharmacol 2011, 162:917-928.
12. Boeckxstaens G.E., de Jonge W.J. Neuroimmune mechanisms in postoperative ileus. Gut 2009, 58:1300-1311.
13. Boland C., Collet V., Laterre E., et al. Electrical vagus nerve stimulation and nicotine effects in peritonitis-induced acute lung injury in rats. Inflammation 2011, 34:29-35.
14. Borovikova L.V., Ivanova S., Zhang M., et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000, 405:458-462.
15. Borovikova L.V., Ivanova S., Nardi D., et al. Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation. Auton Neurosci 2000, 85:141-147.
16. Bouzat C., Gumilar F., Spitzmaul G., et al. Coupling of agonist binding to channel gating in an ACh-binding protein linked to an ion channel. Nature 2004, 430:896-900.
17. Buijs R.M., van der Vliet J., Garidou M.L., et al. Spleen vagal denervation inhibits the production of antibodies to circulating antigens. PLoS One 2008, 3:e3152.
18. Bunch T.J., White RD R., Gersh B.J., et al. Long-term outcomes of out-of-hospital cardiac arrest after successful early defibrillation. N Engl J Med 2003, 348:2626-2633.
19. Cailotto C., Costes L.M., van der Vliet J., et al. Neuroanatomical evidence demonstrating the existence of the vagal anti-inflammatory reflex in the intestine. Neurogastroenterol Motil. 2012, 24:191-200.
20. Chernyavsky A.I., Arredondo J., Galitovskiy V., et al. Upregulation of nuclear factor-kappaB expression by SLURP-1 is mediated by alpha7-nicotinic acetylcholine receptor and involves both ionic events and activation of protein kinases. Am J Physiol Cell Physiol 2010, 299:C903-C911.
21. Cheyuo C., Wu R., Zhou M., et al. Ghrelin suppresses inflammation and neuronal nitric oxide synthase in focal cerebral ischemia via the vagus nerve. Shock 2011, 35:258-265.
22. Choi K.M., Gibbons S.J., Nguyen T.V., et al. Heme oxygenase-1 protects interstitial cells of Cajal from oxidative stress and reverses diabetic gastroparesis. Gastroenterology 2008, 135:2055-2064. 2064 e1-e2.
23. Choi K.M., Kashyap P.V., Dutta N., et al. CD206-positive M2 macrophages that express heme oxygenase-1 protect against diabetic gastroparesis in mice. Gastroenterology 2010, 138:2399-2409. 2409 e1.
24. Corcoran C., Connor T.J., O'Keane V., et al. The effects of vagus nerve stimulation on pro- and anti-inflammatory cytokines in humans: a preliminary report. Neuroimmunomodulation 2005, 12:307-309.
25. Crockett E.T., Galligan J.J., Uhal B.D., et al. Protection of early phase hepatic ischemia-reperfusion injury by cholinergic agonists. BMC Clin Pathol 2006, 6:3.
26. Danese S., Colombel J.F., Reinisch W., et al. Review article: infliximab for Crohn's disease treatment - shifting therapeutic strategies after 10 years of clinical experience. Aliment Pharmacol Ther 2011, 33:857-869.
27. Danton G.H., Dietrich W.D. Inflammatory mechanisms after ischemia and stroke. J Neuropathol Exp Neurol 2003, 62:127-136.
28. de Haan J.J., Lubbers T., Hadfoune M., et al. Postshock intervention with high-lipid enteral nutrition reduces inflammation and tissue damage. Ann Surg 2008, 248:842-848.
29. de Haan J.J., Thuijls G., Lubbers T., et al. Protection against early intestinal compromise by lipid-rich enteral nutrition through cholecystokinin receptors. Crit Care Med 2010, 38:1592-1597.
30. De Herdt V., Bogaert S., Bracke K.R., et al. Effects of vagus nerve stimulation on pro- and anti-inflammatory cytokine induction in patients with refractory epilepsy. J Neuroimmunol 2009, 214:104-108.
31. de Jonge W.J., Ulloa L. The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation. Br J Pharmacol 2007, 151:915-929.
32. de Jonge W.J., van der Zanden E.P., The F.O., et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 2005, 6:844-851.
33. De Rosa M.J., Dionisio L., Agriello E., et al. Alpha 7 nicotinic acetylcholine receptor modulates lymphocyte activation. Life Sci 2009, 85:444-449.
34. de Winter B.Y., van Nassauw L., de Man J.G., et al. Role of oxidative stress in the pathogenesis of septic ileus in mice. Neurogastroenterol Motil 2005, 17:251-261.
35. Eskandari M.K., Kalff J.C., Billiar T.R., et al. Lipopolysaccharide activates the muscularis macrophage network and suppresses circular smooth muscle activity. Am J Physiol 1997, 273:G727-G734.
36. Eskandari M.K., Kalff J.C., Billiar T.R., et al. LPS-induced muscularis macrophage nitric oxide suppresses rat jejunal circular muscle activity. Am J Physiol 1999, 277:G478-G486.
37. Fallgatter A.J., Neuhauser B., Herrmann M.J., et al. Far field potentials from the brain stem after transcutaneous vagus nerve stimulation. J Neural Transm 2003, 110:1437-1443.
38. Fallgatter A.J., Ehlis A.C., Ringel T.M., et al. Age effect on far field potentials from the brain stem after transcutaneous vagus nerve stimulation. Int J Psychophysiol 2005, 56:37-43.
39. Gallowitsch-Puerta M., Tracey K.J. Immunologic role of the cholinergic anti-inflammatory pathway and the nicotinic acetylcholine alpha 7 receptor. Ann N Y Acad Sci 2005, 1062:209-219.
40. Garcia-Guzman M., Sala F., Sala S., et al. alpha-Bungarotoxin-sensitive nicotinic receptors on bovine chromaffin cells: molecular cloning, functional expression and alternative splicing of the alpha 7 subunit. Eur J Neurosci 1995, 7:647-655.
41. Gault J., Robinson M., Berger R., et al. Genomic organization and partial duplication of the human alpha7 neuronal nicotinic acetylcholine receptor gene (CHRNA7). Genomics 1998, 52:173-185.
42. Ghia J.E., Blennerhassett P., Kumar-Ondiveeran H., et al. The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology 2006, 131:1122-1130.
43. Ghia J.E., Blennerhassett P., El-Sharkawy R.T., et al. The protective effect of the vagus nerve in a murine model of chronic relapsing colitis. Am J Physiol Gastrointest Liver Physiol 2007, 293:G711-G718.
44. Ghia J.E., Blennerhassett P., Collins S.M. Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression. J Clin Invest 2008, 118:2209-2218.
45. Ghia J.E., Blennerhassett P., Deng Y., et al. Reactivation of inflammatory bowel disease in a mouse model of depression. Gastroenterology 2009, 136:2280-2288. e1-4.
46. Ghia J.E., Park A.J., Blennerhassett P., et al. Adoptive transfer of macrophage from mice with depression-like behavior enhances susceptibility to colitis. Inflamm Bowel Dis 2011, 17:1474-1489.
47. Giebelen I.A., Le Moine A., van den Pangaart P.S., et al. Deficiency of alpha7 cholinergic receptors facilitates bacterial clearance in Escherichia coli peritonitis. J Infect Dis 2008, 198:750-757.
48. Goehler L.E., Relton J.K., Dripps D., et al. Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: a possible mechanism for immune-to-brain communication. Brain Res Bull 1997, 43:357-364.
49. Goldhammer E., Tanchilevitch A., Maor I., et al. Exercise training modulates cytokines activity in coronary heart disease patients. Int J Cardiol 2005, 100:93-99.
50. Goldstein R.S., Bruchfeld A., Yang L., et al. Cholinergic anti-inflammatory pathway activity and high mobility group box-1 (HMGB1) serum levels in patients with rheumatoid arthritis. Mol Med 2007, 13:210-215.
51. Groves D.A., Brown V.J. Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects. Neurosci Biobehav Rev 2005, 29:493-500.
52. Guarini S., Cainazzo M.M., Giuliani D., et al. Adrenocorticotropin reverses hemorrhagic shock in anesthetized rats through the rapid activation of a vagal anti-inflammatory pathway. Cardiovasc Res 2004, 63:357-365.
53. Guinet E., Yoshida K., Nouri-Shirazi M. Nicotinic environment affects the differentiation and functional maturation of monocytes derived dendritic cells (DCs). Immunol Lett 2004, 95:45-55.
54. Haarala A., Kähönen M., Eklund C., et al. Heart rate variability is independently associated with C-reactive protein but not with Serum amyloid A. The Cardiovascular Risk in Young Finns Study. Eur J Clin Invest 2011, 41:951-957.
55. Haensel A., Mills P.J., Nelesen R.A., et al. The relationship between heart rate variability and inflammatory markers in cardiovascular diseases. Psychoneuroendocrinology 2008, 33:1305-1312.
56. Hansen M.K., O'Connor K.A., Goehler L.E., et al. The contribution of the vagus nerve in interleukin-1beta-induced fever is dependent on dose. Am J Physiol Regul Integr Comp Physiol 2001, 280:R929-R934.
57. Hofer S., Eisenbach C., Lukic I.K., et al. Pharmacologic cholinesterase inhibition improves survival in experimental sepsis. Crit Care Med 2008, 36:404-408.
58. Holguin F., Tellez-Rojo M.M., Lazo M., et al. Cardiac autonomic changes associated with fish oil vs soy oil supplementation in the elderly. Chest 2005, 127:1102-1107.
59. Huston J.M., Tracey K.J. The pulse of inflammation: heart rate variability, the cholinergic anti-inflammatory pathway and implications for therapy. J Intern Med 2011, 269:45-53.
60. Huston J.M., Ochani M., Rosas-Ballina M., et al. Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med 2006, 203:1623-1628.
61. Huston J.M., Wang H., Ochani M., et al. Splenectomy protects against sepsis lethality and reduces serum HMGB1 levels. J Immunol 2008, 181:3535-3539.
62. Huston J.M., Rosas-Ballina M., Xue X., et al. Cholinergic neural signals to the spleen down-regulate leukocyte trafficking via CD11b. J Immunol 2009, 183:552-559.
63. Ingram J.R., Thomas G.A., Rhodes J., et al. A randomized trial of nicotine enemas for active ulcerative colitis. Clin Gastroenterol Hepatol 2005, 3:1107-1114.
64. Kalff J.C., Schraut W.H., Simmons R.L., et al. Surgical manipulation of the gut elicits an intestinal muscularis inflammatory response resulting in postsurgical ileus. Ann Surg 1998, 228:652-663.
65. Kalff J.C., Buchholz B.M., Eskandari M.K., et al. Biphasic response to gut manipulation and temporal correlation of cellular infiltrates and muscle dysfunction in rat. Surgery 1999, 126:498-509.
66. Kong S.S., Liu J.J., Hwang T.C., et al. Tumour necrosis factor-alpha and its receptors in the beneficial effects of vagal stimulation after myocardial infarction in rats. Clin Exp Pharmacol Physiol 2011, 38:300-306.
67. Koopman F.A., Stoof S.P., Straub R.H., et al. Restoring the balance of the autonomic nervous system as an innovative approach to the treatment of rheumatoid arthritis. Mol Med 2011, 17:937-948.
68. Kox M., Pompe J.C., Pickkers P., et al. Increased vagal tone accounts for the observed immune paralysis in patients with traumatic brain injury. Neurology 2008, 70:480-485.
69. Kox M., van Velzen J.F., Pompe J.C., et al. GTS-21 inhibits pro-inflammatory cytokine release independent of the Toll-like receptor stimulated via a transcriptional mechanism involving JAK2 activation. Biochem Pharmacol 2009, 78:863-872.
70. Kox M., Pompe J.C., Gordinou de Gouberville M.C., et al. Effects of the alpha7 nicotinic acetylcholine receptor agonist Gts-21 on the innate immune response in humans. Shock 2011, 36:5-11.
71. Lanza G.A., Sgueglia G.A., Cianflone D., et al. Relation of heart rate variability to serum levels of C-reactive protein in patients with unstable angina pectoris. Am J Cardiol 2006, 97:1702-1706.
72. Lubbers T., Luyer M.D., de Haan J.J., et al. Lipid-rich enteral nutrition reduces postoperative ileus in rats via activation of cholecystokinin-receptors. Ann Surg 2009, 249:481-487.
73. Lubbers T., de Haan J.J., Hadfoune M., et al. Lipid-enriched enteral nutrition controls the inflammatory response in murine Gram-negative sepsis. Crit Care Med 2010, 38:1996-2002.
74. Lubbers T., de Haan J.J., Luyer M.D., et al. Cholecystokinin/cholecystokinin-1 receptor-mediated peripheral activation of the afferent vagus by enteral nutrients attenuates inflammation in rats. Ann Surg 2010, 252:376-382.
75. Lubbers T., de Haan J.J., Hadfoune M., et al. Chylomicron formation and glucagon-like peptide 1 receptor are involved in activation of the nutritional anti-inflammatory pathway. J Nutr Biochem 2011, 22:1105-1111.
76. Luyer M.D., Greve J.W., Hadfoune M., et al. Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve. J Exp Med 2005, 202:1023-1029.
77. Marquette C., Linard C., Galonnier M., et al. IL-1beta, TNFalpha and IL-6 induction in the rat brain after partial-body irradiation: role of vagal afferents. Int J Radiat Biol 2003, 79:777-785.
78. Marsland A.L., Gianaros P.J., Prather A.A., et al. Stimulated production of proinflammatory cytokines covaries inversely with heart rate variability. Psychosom Med 2007, 69:709-716.
79. Marvel F.A., Chen C.C., Badr N., et al. Reversible inactivation of the dorsal vagal complex blocks lipopolysaccharide-induced social withdrawal and c-Fos expression in central autonomic nuclei. Brain Behav Immun 2004, 18:123-134.
80. Matteoli G, Gomez-Pinilla PJ, Nemethova A et al. A distinct vagal anti-inflammatory pathway modulates intestinal muscularis resident macrophages independent of the spleen. Gut. (in press).
81. McGrath J., McDonald J.W., Macdonald J.K. Transdermal nicotine for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2004, CD004722.
82. McLane K.E., Wu X.D., Conti-Tronconi B.M. Identification of a brain acetylcholine receptor alpha subunit able to bind alpha-bungarotoxin. J Biol Chem 1990, 265:9816-9824.
83. Miceli P.C., Jacobson K. Cholinergic pathways modulate experimental dinitrobenzene sulfonic acid colitis in rats. Auton Neurosci 2003, 105:16-24.
84. Mikulski Z., Hartmann P., Jositsch G., et al. Nicotinic receptors on rat alveolar macrophages dampen ATP-induced increase in cytosolic calcium concentration. Respir Res 2010, 11:133.
85. Minnicozzi M., Sawyer R.T., Fenton M.J. Innate immunity in allergic disease. Immunol Rev 2011, 242:106-127.
86. Minutoli L., Squadrito F., Nicotina P.A., et al. Melanocortin 4 receptor stimulation decreases pancreatitis severity in rats by activation of the cholinergic anti-inflammatory pathway. Crit Care Med 2011, 39:1089-1096.
87. Nikfar S., Ehteshami-Ashar S., Rahimi R., et al. Systematic review and meta-analysis of the efficacy and tolerability of nicotine preparations in active ulcerative colitis. Clin Ther 2010, 32:2304-2315.
88. Norman G.J., Morris J.S., Karelina K., et al. Cardiopulmonary arrest and resuscitation disrupts cholinergic anti-inflammatory processes: a role for cholinergic alpha7 nicotinic receptors. J Neurosci 2011, 31:3446-3452.
89. O'Mahony C., van der Kleij H., Bienenstock J., et al. Loss of vagal anti-inflammatory effect: in vivo visualization and adoptive transfer. Am J Physiol Regul Integr Comp Physiol 2009, 297:R1118-R1126.
90. Olincy A., Harris J.G., Johnson L.L., et al. Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. Arch Gen Psychiatry 2006, 63:630-638.
91. Orr-Urtreger A., Kedmi M., Rosner S., et al. Increased severity of experimental colitis in alpha 5 nicotinic acetylcholine receptor subunit-deficient mice. Neuroreport 2005, 16:1123-1127.
92. Ottani A., Giuliani D., Mioni C., et al. Vagus nerve mediates the protective effects of melanocortins against cerebral and systemic damage after ischemic stroke. J Cereb Blood Flow Metab 2009, 29:512-523.
93. Ottani A., Giuliani D., Galantucci M., et al. Melanocortins counteract inflammatory and apoptotic responses to prolonged myocardial ischemia/reperfusion through a vagus nerve-mediated mechanism. Eur J Pharmacol 2010, 637:124-130.
94. Panacek E.A., Marshall J.C., Albertson T.E., et al. Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab')2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels. Crit Care Med 2004, 32:2173-2182.
95. Parrish W.R., Rosas-Ballina M., Gallowitsch-Puerta M., et al. Modulation of TNF release by choline requires alpha7 subunit nicotinic acetylcholine receptor-mediated signaling. Mol Med 2008, 14:567-574.
96. Pavlov V.A. Cholinergic modulation of inflammation. Int J Clin Exp Med 2008, 1:203-212.
97. Pavlov V.A., Ochani M., Gallowitsch-Puerta M., et al. Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia. Proc Natl Acad Sci U S A 2006, 103:5219-5223.
98. Pavlov V.A., Parrish W.R., Rosas-Ballina M., et al. Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Brain Behav Immun 2009, 23:41-45.
99. Peter C., Schmidt K., Hofer S., et al. Effects of physostigmine on microcirculatory alterations during experimental endotoxemia. Shock 2010, 33:405-411.
100. Qin S., Wang H., Yuan R., et al. Role of HMGB1 in apoptosis-mediated sepsis lethality. J Exp Med 2006, 203:1637-1642.
101. Rescigno M. Intestinal dendritic cells. Adv Immunol 2010, 107:109-138.
102. Rosas-Ballina M., Goldstein R.S., Gallowitsch-Puerta M., et al. The selective alpha7 agonist GTS-21 attenuates cytokine production in human whole blood and human monocytes activated by ligands for TLR2, TLR3, TLR4, TLR9, and RAGE. Mol Med 2009, 15:195-202.
103. Rutgeerts P., Vermeire S., Van Assche G. Biological therapies for inflammatory bowel diseases. Gastroenterology 2009, 136:1182-1197.
104. Sadis C., Teske G., Stokman G., et al. Nicotine protects kidney from renal ischemia/reperfusion injury through the cholinergic anti-inflammatory pathway. PLoS One 2007, 2:e469.
105. Saeed R.W., Varma S., Peng-Nemeroff T., et al. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med 2005, 201:1113-1123.
106. Schenten D., Medzhitov R. The control of adaptive immune responses by the innate immune system. Adv Immunol 2011, 109:87-124.
107. Sharma G., Vijayaraghavan S. Nicotinic receptors containing the alpha7 subunit: a model for rational drug design. Curr Med Chem 2008, 15:2921-2932.
108. Sloan R.P., McCreath H., Tracey K.J., et al. RR interval variability is inversely related to inflammatory markers: the CARDIA study. Mol Med 2007, 13:178-184.
109. Snoek S.A., Verstege M.I., van der Zanden E.P., et al. Selective alpha7 nicotinic acetylcholine receptor agonists worsen disease in experimental colitis. Br J Pharmacol 2010, 160:322-333.
110. Sternberg E.M. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat Rev Immunol 2006, 6:318-328.
111. Takahashi H.K., Liu K., Wake H., et al. Effect of nicotine on advanced glycation end product-induced immune response in human monocytes. J Pharmacol Exp Ther 2010, 332:1013-1021.
112. The F.O., Boeckxstaens G.E., Snoek S.A., et al. Activation of the cholinergic anti-inflammatory pathway ameliorates postoperative ileus in mice. Gastroenterology 2007, 133:1219-1228.
113. The F., Cailotto C., van der Vliet J., et al. Central activation of the cholinergic anti-inflammatory pathway reduces surgical inflammation in experimental post-operative ileus. Br J Pharmacol 2011, 163:1007-1016.
114. Thomsen M.S., Hansen H.H., Timmerman D.B., et al. Cognitive improvement by activation of alpha7 nicotinic acetylcholine receptors: from animal models to human pathophysiology. Curr Pharm Des 2010, 16:323-343.
115. Toyohara J., Hashimoto K. alpha7 Nicotinic receptor agonists: potential therapeutic drugs for treatment of cognitive impairments in schizophrenia and Alzheimer's disease. Open Med Chem J. 2010, 4:37-56.
116. Tracey K.J. The inflammatory reflex. Nature 2002, 420:853-859.
117. Tracey K.J. Reflex control of immunity. Nat Rev Immunol 2009, 9:418-428.
118. Tregellas J.R., Olincy A., Johnson L., et al. Functional magnetic resonance imaging of effects of a nicotinic agonist in schizophrenia. Neuropsychopharmacology 2010, 35:938-942.
119. Tregellas J.R., Tanabe J., Rojas D.C., et al. Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia. Biol Psychiatry 2011, 69:7-11.
120. Turler A., Schwarz N.T., Turler E., et al. MCP-1 causes leukocyte recruitment and subsequently endotoxemic ileus in rat. Am J Physiol Gastrointest Liver Physiol 2002, 282:G145-G155.
121. Tyagi E., Agrawal R., Nath C., et al. Cholinergic protection via alpha7 nicotinic acetylcholine receptors and PI3K-Akt pathway in LPS-induced neuroinflammation. Neurochem Int 2010, 56:135-142.
122. Tyagi E., Agrawal R., Nath C., et al. Inhibitory role of cholinergic system mediated via alpha7 nicotinic acetylcholine receptor in LPS-induced neuro-inflammation. Innate Immun 2010, 16:3-13.
123. Ulloa L. The vagus nerve and the nicotinic anti-inflammatory pathway. Nat Rev Drug Discov 2005 May, 4:673-684.
124. Van Assche G., Vermeire S., Rutgeerts P. Management of acute severe ulcerative colitis. Gut 2011, 60:130-133.
125. van der Zanden E.P., Snoek S.A., Heinsbroek S.E., et al. Vagus nerve activity augments intestinal macrophage phagocytosis via nicotinic acetylcholine receptor alpha4beta2. Gastroenterology 2009, 137:1029-1039. 1039 e1-4.
126. van Maanen M.A., Lebre M.C., van der Poll T., et al. Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice. Arthritis Rheum 2009, 60:114-122.
127. van Maanen M.A., Vervoordeldonk M.J., Tak P.P. The cholinergic anti-inflammatory pathway: towards innovative treatment of rheumatoid arthritis. Nat Rev Rheumatol 2009, 5:229-232.
128. van Maanen M.A., Stoof S.P., Larosa G.J., et al. Role of the cholinergic nervous system in rheumatoid arthritis: aggravation of arthritis in nicotinic acetylcholine receptor alpha7 subunit gene knockout mice. Ann Rheum Dis 2010, 69:1717-1723.
129. van Westerloo D.J., Giebelen I.A., Florquin S., et al. The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. J Infect Dis 2005, 191:2138-2148.
130. von Känel R., Nelesen R.A., Mills P.J., et al. Relationship between heart rate variability, interleukin-6, and soluble tissue factor in healthy subjects. Brain Behav Immun 2008, 22:461-468.
131. Wallace T.L., Ballard T.M., Pouzet B., et al. Drug targets for cognitive enhancement in neuropsychiatric disorders. Pharmacol Biochem Behav 2011, 99:130-145.
132. Wang H., Bloom O., Zhang M., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248-251.
133. Wang H., Yu M., Ochani M., et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003, 421:384-388.
134. Wang H., Liao H., Ochani M., et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 2004, 10:1216-1221.
135. Watkins L.R., Goehler L.E., Relton J.K., et al. Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication. Neurosci Lett 1995, 183:27-31.
136. Weber C.S., Thayer J.F., Rudat M., et al. Low vagal tone is associated with impaired post stress recovery of cardiovascular, endocrine, and immune markers. Eur J Appl Physiol 2010, 109:201-211.
137. Wehner S., Behrendt F.F., Lyutenski B.N., et al. Inhibition of macrophage function prevents intestinal inflammation and postoperative ileus in rodents. Gut 2007, 56:176-185.
138. Wessler I., Kirkpatrick C.J. Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br J Pharmacol 2008, 154:1558-1571.
139. Westman M., Engstrom M., Catrina A.I., et al. Cell specific synovial expression of nicotinic alpha 7 acetylcholine receptor in rheumatoid arthritis and psoriatic arthritis. Scand J Immunol 2009, 70:136-140.
140. Wu R., Dong W., Cui X., et al. Ghrelin down-regulates proinflammatory cytokines in sepsis through activation of the vagus nerve. Ann Surg 2007, 245:480-486.
141. Wu R., Dong W., Ji Y., et al. Orexigenic hormone ghrelin attenuates local and remote organ injury after intestinal ischemia-reperfusion. PLoS One 2008, 3:e2026.
142. Yeboah M.M., Xue X., Duan B., et al. Cholinergic agonists attenuate renal ischemia-reperfusion injury in rats. Kidney Int 2008, 74:62-69.
143. Zamora R., Grishin A., Wong C., et al. High-mobility group box 1 protein is an inflammatory mediator in necrotizing enterocolitis: protective effect of the macrophage deactivator semapimod. Am J Physiol Gastrointest Liver Physiol 2005, 289:G643-G652.
144. Zhang P., Han D., Tang T., et al. Inhibition of the development of collagen-induced arthritis in Wistar rats through vagus nerve suspension: a 3-month observation. Inflamm Res 2008, 57:322-328.